OMEROS CORP
For the period ended Jun 30, 2025. Filed Aug 14, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 14, 2025
OMER$17.30-1.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Equity (Deficit)
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’** DEFICIT**
(In thousands, except share data)
| Additional | |||||
|---|---|---|---|---|---|
| Common Stock · Paid-In · Accumulated | |||||
| Shares | Amount | Capital | Deficit | Total | |
| Balance at January 1, 2025 | 58,044,465 | $580 | $727,156 | $(910,345) | $(182,609) |
| Issuance of common stock upon exercise of stock options | 19,436 | — | 63 | — | 63 |
| Stock-based compensation expense | — | — | 2,453 | — | 2,453 |
| Net loss | — | — | — | (33,460) | (33,460) |
| Balance at March 31, 2025 | 58,063,901 | 580 | 729,672 | (943,805) | (213,553) |
| Issuance of common stock upon exercise of stock options | 7,266 | — | 25 | — | 25 |
| Stock-based compensation expense | — | — | 2,065 | — | 2,065 |
| Issuance of common stock - at-the-market equity offering facility, net | 1,411,845 | 13 | 6,274 | — | 6,287 |
| Issuance of common stock - 2026 Notes equitization | 539,320 | 6 | 1,909 | — | 1,915 |
| Net loss | — | — | — | (25,424) | (25,424) |
| Balance at June 30, 2025 | 60,022,332 | $599 | $739,945 | $(969,229) | $(228,685) |
| Balance at January 1, 2024 | 61,128,597 | $611 | $727,936 | $(753,530) | $(24,983) |
| Issuance of common stock upon exercise of stock options | 9,339 | — | 32 | — | 32 |
| Repurchases of common stock | (3,195,241) | (32) | (11,819) | — | (11,851) |
| Stock-based compensation expense | — | — | 2,658 | — | 2,658 |
| Net loss | — | — | — | (37,184) | (37,184) |
| Balance at March 31, 2024 | 57,942,695 | 579 | 718,807 | (790,714) | (71,328) |
| Issuance of common stock upon exercise of stock options | 1,464 | — | 3 | — | 3 |
| Stock-based compensation expense | — | — | 2,768 | — | 2,768 |
| Net loss | — | — | — | (56,041) | (56,041) |
| Balance at June 30, 2024 | 57,944,159 | $579 | $721,578 | $(846,755) | $(124,598) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.